Selected article for: "accessible care and acute respiratory syndrome"

Author: Fragala, Maren S.; Goldberg, Zachary N.; Goldberg, Steven E.
Title: Return to Work: Managing Employee Population Health During the COVID-19 Pandemic
  • Cord-id: o0ggot9v
  • Document date: 2021_2_1
  • ID: o0ggot9v
    Snippet: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has abruptly transformed the outlook of employer health benefits plans for 2020 and 2021. Containing the spread of the virus and facilitating care of those infected have quickly emerged as immediate priorities. Employers have adjusted health benefits coverage to make COVID-19 testing and treatment accessible and remove barriers to care in order to facilitate the containment of the dis
    Document: Coronavirus disease-2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has abruptly transformed the outlook of employer health benefits plans for 2020 and 2021. Containing the spread of the virus and facilitating care of those infected have quickly emerged as immediate priorities. Employers have adjusted health benefits coverage to make COVID-19 testing and treatment accessible and remove barriers to care in order to facilitate the containment of the disease. Employers also are introducing strategies focused on testing, surveillance, workplace modifications, and hygiene to keep workforces healthy and workplaces safe. This paper is intended to provide evidence-based perspectives for self-insured employers for managing population health during the COVID-19 pandemic. Such considerations include (1) return to work practices focused on mitigating the spread of COVID-19 through safety practices, testing and surveillance; and (2) anticipating the impact of COVID-19 on health benefits and costs (including adaptations in delivery of care, social and behavioral health needs, and managing interrupted care for chronic conditions).

    Search related documents:
    Co phrase search for related documents
    • abbott laboratories and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6
    • abbott laboratories and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • access increase and acid amplification: 1, 2
    • access increase and acid amplification test: 1
    • access increase and acute illness: 1, 2
    • access increase and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • access increase and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • access program and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6
    • access program and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acid amplification and active virus: 1
    • acid amplification and acute illness: 1, 2, 3, 4, 5, 6
    • acid amplification and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid amplification and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acid amplification test and acute illness: 1
    • acid amplification test and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acid amplification test and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acquire immunity and acute respiratory coronavirus: 1, 2, 3, 4
    • acquire immunity and acute respiratory syndrome: 1, 2, 3, 4
    • active virus and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25